Privium Fund Management’s Revelation Biosciences Warrant REVBW Stock Holding History

Privium Fund Management’s Portfolio REVBW Stock Details REVBW Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2024 Q3	–	Sell	-44,000	Closed	-$752	–	118
2024 Q2	$752	Hold	44,000	–	–	﹤0.01%	129
2024 Q1	$1.17K	Hold	44,000	–	–	﹤0.01%	116
2023 Q4	$466	Hold	44,000	–	–	﹤0.01%	113
2023 Q3	$744	Hold	44,000	–	–	﹤0.01%	115
2023 Q2	$880	Hold	44,000	–	–	﹤0.01%	122
2023 Q1	$713	Hold	44,000	–	–	﹤0.01%	124
2022 Q4	$497	Hold	44,000	–	–	﹤0.01%	144
2022 Q3	$2K	Hold	44,000	–	–	﹤0.01%	188
2022 Q2	$4K	Hold	44,000	–	–	﹤0.01%	200
2022 Q1	$6K	Hold	44,000	–	–	﹤0.01%	257
2021 Q4	$29K	Buy	+44,000	New	+$27K	0.01%	184

Other funds holding REVBW

Linden Advisors New York $17.9B AUM 1.72% 1-Year Est. Return

Yakira Capital Management Westport, Connecticut $342M AUM 26.97% 1-Year Est. Return

Walleye Capital

Walleye Capital New York $16.3B AUM 37.67% 1-Year Est. Return

Pine Valley Investments Marlton, New Jersey $2.05B AUM 26.57% 1-Year Est. Return

Walleye Trading

Walleye Trading New York $4.86B AUM 42.19% 1-Year Est. Return

Cowen and Company New York $2.9B AUM 105.26% 1-Year Est. Return

Jane Street New York $93.1B AUM 61.18% 1-Year Est. Return

Citadel Advisors

Citadel Advisors Miami, Florida $141B AUM 30.34% 1-Year Est. Return

Wolverine Asset Management Chicago, Illinois $6.41B AUM 4.78% 1-Year Est. Return

Two Sigma Securities New York $861M AUM 21.33% 1-Year Est. Return